Citations

Citations to this article as recorded by  

• Isolation and characterization of a potent bacteriophage KA targeting an antibiotic-resistant human pathogenic strain of Klebsiella pneumoniae KP1
  Aneela Nawaz, Nauman Ahmed Khalid, Sidra Zaheer, Muhammad Ismail Khan, Ali Khalid, Aamer Ali Shah, Malik Badshah, Samiullah Khan
  Microbial Pathogenesis.2026; 210: 108150.     CrossRef
• Characterization and antibiofilm efficacy of the Pseudomonas aeruginosa phage HKPH_J3
  Jinyue Zhang, Yao Li, Tianheng Xue, Haoyu Li, Hanqi Wei, Xiaoxiao Li, Wanlian Zhang, Shihao Song
  International Journal of Medical Microbiology.2026; 322: 151706.     CrossRef
• Bacteriophage Therapy: Current Strategies and Future Perspectives
  Zihe Zhou, Hanyu Fu, Mengzhe Li, Zhongyu Han, Zhenchao Wu, Huahao Fan, Ning Shen, Jiajia Zheng
  MedComm.2026;[Epub]     CrossRef
• Comparative Study of Bacteriophage Pharmacokinetics by Different Enteral Administration Routes
  Maria Anurova, Aleksey Kuzmin, Aleksey Vorobev, Nataliya Feldman, Elena Zinurova, Andrey Aleshkin
  Methods and Protocols.2026; 9(3): 89.     CrossRef
• Comparison and correlation of in vitro and in vivo approaches for determining Pseudomonas aeruginosa bacteriophages activity
  Pedro Henrique Takata, Giovana Nicolete Pereira, Jhonatan Macedo Ribeiro, Laura Pierobão, Gabriel Henrique Maximino Santos, Bruna Carolina Gonçalves, Pedro Ademário Lima e Silva, Mariana Marques Bertozzi, Rafael Reis de Rezende, Giarlã Cunha da Silva, Rui
  BMC Microbiology.2026;[Epub]     CrossRef
• Breaking down barriers to improve phage therapy delivery
  Tiffany Luong, Izabela Rybicka, Patrick Blankenberg, Krystyna Dąbrowska, Paul L. Bollyky
  Cell Host & Microbe.2026; 34(7): 1285.     CrossRef
• Modeling Phage–Antibiotic Synergy, Innate Immunity, and Phage Resistance in Multidrug-Resistant Acinetobacter baumannii
  Alma Karen Orozco-Ochoa, José Benigno Valdez-Torres, Jean Pierre González-Gómez, Nohelia Castro-del Campo, Cristóbal Chaidez-Quiroz
  Antibiotics.2026; 15(9): 919.     CrossRef
• Bridging the gap between experimental evidence and clinical applications of antipseudomonal phage therapy against Pseudomonas aeruginosa
  Ahmed Elfadadny, Wedad M. Nageeb, Rokaia F. Ragab, Hazim O. Khalifa
  Biomedicine & Pharmacotherapy.2026; 204: 119894.     CrossRef
• Bacteriophages as Immune Modulators: Current Insights and Future Directions
  Kollawat Somsri, Nuttawut Sutnu, Sirikan Montathip, Thansita Bhunyakarnjanarat, Marcus J. Schultz, Kent Doi, Wiwat Chancharoenthana, Asada Leelahavanichkul
  PHAGE: Therapy, Applications, and Research.2026; 7(2): 108.     CrossRef
• Phage-induced protection against lethal bacterial reinfection
  Yikun Xing, Haroldo J. Hernandez Santos, Ling Qiu, Samantha R. Ritter, Jacob J. Zulk, Rachel Lahowetz, Kathryn A. Patras, Austen L. Terwilliger, Anthony W. Maresso
  Proceedings of the National Academy of Sciences.2025;[Epub]     CrossRef
• RETRACTED: Bacteriophages as an alternative strategy for the treatment of drug resistant bacterial infections: Current approaches and future perspectives
  Abayeneh Girma
  The Cell Surface.2025; 14: 100149.     CrossRef
• Multi-strain phage induced clearance of bacterial infections
  Jacopo Marchi, Chau Nguyen Ngoc Minh, Laurent Debarbieux, Joshua S Weitz, Rob J De Boer
  PLOS Computational Biology.2025; 21(2): e1012793.     CrossRef
• Overcoming Pseudomonas aeruginosa in Chronic Suppurative Lung Disease: Prevalence, Treatment Challenges, and the Promise of Bacteriophage Therapy
  Jagdev Singh, Melinda Solomon, Jonathan Iredell, Hiran Selvadurai
  Antibiotics.2025; 14(5): 427.     CrossRef
• Isolation and identification of a newly discovered broad-spectrum Acinetobacter baumannii phage and therapeutic validation against pan-resistant Acinetobacter baumannii
  Miaomiao Lin, Lele Xiong, Wen Li, Lingyan Xiao, Wei Zhang, Xiaogui Zhao, Yishan Zheng
  Virologica Sinica.2025; 40(4): 587.     CrossRef
• Overcoming antimicrobial resistance: Phage therapy as a promising solution to combat ESKAPE pathogens
  Ritu Raj Patel, Pandey Priya Arun, Sudhir Kumar Singh, Meenakshi Singh
  International Journal of Antimicrobial Agents.2025; 66(6): 107640.     CrossRef
• Phage-mediated TLR2 signaling attenuates intracellular Mycobacterium abscessus survival in macrophages
  Hannah Kapoor, Aaron M. Maves, Madeline A. Bowder, Lia Danelishvili
  Scientific Reports.2025;[Epub]     CrossRef
• Neutrophils, not macrophages, aid phage-mediated control of pulmonary Pseudomonas aeruginosa infection
  Chantal Weissfuss, Karen Hoffmann, Ulrike Behrendt, Magdalena Bürkle, Shailey G. Twamley, Imke H. E. Korf, Katharina Ahrens, Christine Rohde, Christian M. Zobel, Laurent Debarbieux, Jean-Damien Ricard, Martin Witzenrath, Geraldine Nouailles
  Frontiers in Immunology.2025;[Epub]     CrossRef
• Mycobacteriophages: therapeutic approach for mycobacterial infections
  Sunil Kumar Raman, D.V. Siva Reddy, Vikas Jain, Urmi Bajpai, Amit Misra, Amit Kumar Singh
  Drug Discovery Today.2024; 29(7): 104049.     CrossRef
• Pseudomonas aeruginosa Bacteriophages and Their Clinical Applications
  Elaheh Alipour-Khezri, Mikael Skurnik, Gholamreza Zarrini
  Viruses.2024; 16(7): 1051.     CrossRef
• Exploiting lung adaptation and phage steering to clear pan-resistant Pseudomonas aeruginosa infections in vivo
  Eleri A. Ashworth, Rosanna C. T. Wright, Rebecca K. Shears, Janet K. L. Wong, Akram Hassan, James P. J. Hall, Aras Kadioglu, Joanne L. Fothergill
  Nature Communications.2024;[Epub]     CrossRef
• Phage-inspired strategies to combat antibacterial resistance
  Mianzhi Wang, Junxuan Zhang, Jingyi Wei, Lei Jiang, Li Jiang, Yongxue Sun, Zhenling Zeng, Zhiqiang Wang
  Critical Reviews in Microbiology.2024; 50(2): 196.     CrossRef
• Bacteriophages isolated from mouse feces attenuates pneumonia mice caused by Pseudomonas aeruginosa
  Nuttawut Sutnu, Wiwat Chancharoenthana, Supitcha Kamolratanakul, Pornpimol Phuengmaung, Uthaibhorn Singkham-In, Chiratchaya Chongrak, Sirikan Montathip, Dhammika Leshan Wannigama, Tanittha Chatsuwan, Puey Ounjai, Marcus J. Schultz, Asada Leelahavanichkul,
  PLOS ONE.2024; 19(7): e0307079.     CrossRef
• Evaluation of the impact of repeated intravenous phage doses on mammalian host–phage interactions
  Xin Tan, Kai Chen, Zhihuan Jiang, Ziqiang Liu, Siyun Wang, Yong Ying, Jieqiong Zhang, Shengjian Yuan, Zhipeng Huang, Ruyue Gao, Min Zhao, Aoting Weng, Yongqing Yang, Huilong Luo, Daizhou Zhang, Yingfei Ma, Kristin N. Parent
  Journal of Virology.2024;[Epub]     CrossRef
• The contribution of neutrophils to bacteriophage clearance and pharmacokinetics in vivo
  Arne Echterhof, Tejas Dharmaraj, Arya Khosravi, Robert McBride, Lynn Miesel, Ju-Hsin Chia, Patrick M. Blankenberg, Kun-Yuan Lin, Chien-Chang Shen, Yu-Ling Lee, Yu-Chuan Yeh, Wei Ting Liao, Francis G. Blankenberg, Krystyna Dąbrowska, Derek F. Amanatullah,
  JCI Insight.2024;[Epub]     CrossRef
• In vivo safety evaluation and tracing of arginylglycylaspartic acid-engineered phage nanofiber in murine model
  Kshitiz Raj Shrestha, Sehoon Kim, Anna Jo, Murali Ragothaman, So Young Yoo
  Journal of Materials Chemistry B.2024; 12(40): 10258.     CrossRef
• Metapopulation model of phage therapy of an acute Pseudomonas aeruginosa lung infection
  Rogelio A. Rodriguez-Gonzalez, Quentin Balacheff, Laurent Debarbieux, Jacopo Marchi, Joshua S. Weitz, Oleg A. Igoshin
  mSystems.2024;[Epub]     CrossRef
• Pharmacokinetics and Biodistribution of Phages and their Current Applications in Antimicrobial Therapy
  Dayeon Kang, Damayanti Bagchi, Irene A. Chen
  Advanced Therapeutics.2024;[Epub]     CrossRef
• Phage therapy: A primer for orthopaedic trauma surgeons
  Baixing Chen, T.Fintan Moriarty, Willem-Jan Metsemakers, Marco Chittò
  Injury.2024; 55: 111847.     CrossRef
• Pharmacokinetics and pharmacodynamics of bacteriophage therapy: a review with a focus on multidrug-resistant Gram-negative bacterial infections
  Maria Siopi, Dimitrios Skliros, Paschalis Paranos, Nikoletta Koumasi, Emmanouil Flemetakis, Spyros Pournaras, Joseph Meletiadis, Graeme N. Forrest
  Clinical Microbiology Reviews.2024;[Epub]     CrossRef
• Phage-Based Therapy in Combination with Antibiotics: A Promising Alternative against Multidrug-Resistant Gram-Negative Pathogens
  Cleo Anastassopoulou, Stefanos Ferous, Aikaterini Petsimeri, Georgia Gioula, Athanasios Tsakris
  Pathogens.2024; 13(10): 896.     CrossRef
• Leveraging mathematical modeling framework to guide regimen strategy for phage therapy
  Zhiyuan Yu, Tiffany Luong, Selenne Banuelos, Andrew Sue, Hwayeon Ryu, Rebecca Segal, Dwayne R. Roach, Qimin Huang, Jaehee Kim
  PLOS Complex Systems.2024; 1(3): e0000015.     CrossRef
• Phage therapy: a revolutionary shift in the management of bacterial infections, pioneering new horizons in clinical practice, and reimagining the arsenal against microbial pathogens
  Subhash Lal Karn, Mayank Gangwar, Rajesh Kumar, Satyanam Kumar Bhartiya, Gopal Nath
  Frontiers in Medicine.2023;[Epub]     CrossRef
• A novel lytic phage exhibiting a remarkable in vivo therapeutic potential and higher antibiofilm activity against Pseudomonas aeruginosa
  Aliaa Abdelghafar, Amira El-Ganiny, Ghada Shaker, Momen Askoura
  European Journal of Clinical Microbiology & Infectious Diseases.2023; 42(10): 1207.     CrossRef
• Phage-host-immune system dynamics in bacteriophage therapy: basic principles and mathematical models
  Dongwoo Chae
  Translational and Clinical Pharmacology.2023; 31(4): 167.     CrossRef
• BACTERIOPHAGE M13 MODULATES THE SEPSIS-RELATED INFLAMMATORY RESPONSES AND ORGAN DAMAGE IN A CLP MODEL
  Arezou Rahimi, Sara Soudi, Saeid Vakilian, Fatemeh Jamshidi-Adegani, Majid Sadeghizadeh, Sulaiman Al-Hashmi
  Shock.2023; 59(3): 493.     CrossRef
• Human Neutrophil Response to Pseudomonas Bacteriophage PAK_P1, a Therapeutic Candidate
  Dwayne R. Roach, Benoît Noël, Sylvie Chollet-Martin, Mathieu de Jode, Vanessa Granger, Laurent Debarbieux, Luc de Chaisemartin
  Viruses.2023; 15(8): 1726.     CrossRef
• Translating phage therapy into the clinic: Recent accomplishments but continuing challenges
  Aleksandra Petrovic Fabijan, Jonathan Iredell, Katarzyna Danis-Wlodarczyk, Razieh Kebriaei, Stephen T. Abedon
  PLOS Biology.2023; 21(5): e3002119.     CrossRef
• Phage therapy for hidradenitis suppurativa: a unique challenge and possible opportunity for personalized treatment of a complex, inflammatory disease
  Lene Bens, Sabrina I Green, Daan Jansen, Tom Hillary, Tine Vanhoutvin, Jelle Matthijnssens, João Sabino, Séverine Vermeire, An Van Laethem, Jeroen Wagemans, Rob Lavigne
  Clinical and Experimental Dermatology.2023; 48(11): 1221.     CrossRef
• Determination of phage load and administration time in simulated occurrences of antibacterial treatments
  Steffen Plunder, Markus Burkard, Ulrich M. Lauer, Sascha Venturelli, Luigi Marongiu
  Frontiers in Medicine.2022;[Epub]     CrossRef
• Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations
  Georgia Mitropoulou, Angela Koutsokera, Chantal Csajka, Sylvain Blanchon, Alain Sauty, Jean-Francois Brunet, Christophe von Garnier, Grégory Resch, Benoit Guery
  European Respiratory Review.2022; 31(166): 220121.     CrossRef
• Modification of the immune response by bacteriophages alters methicillin-resistant Staphylococcus aureus infection
  Tomoya Suda, Tomoko Hanawa, Mayuko Tanaka, Yasunori Tanji, Kazuhiko Miyanaga, Sanae Hasegawa-Ishii, Ken Shirato, Takako Kizaki, Takeaki Matsuda
  Scientific Reports.2022;[Epub]     CrossRef
• Bacteriophage: A new therapeutic player to combat neutrophilic inflammation in chronic airway diseases
  Daniel R. Laucirica, Stephen M. Stick, Luke W. Garratt, Anthony Kicic
  Frontiers in Medicine.2022;[Epub]     CrossRef
• Therapeutic Bacteriophages for Gram-Negative Bacterial Infections in Animals and Humans
  Panagiotis Zagaliotis, Jordyn Michalik-Provasek, Jason Gill, Thomas Walsh
  Pathogens and Immunity.2022; 7(2): 1.     CrossRef
• Circulation of Fluorescently Labelled Phage in a Murine Model
  Zuzanna Kaźmierczak, Joanna Majewska, Magdalena Milczarek, Barbara Owczarek, Krystyna Dąbrowska
  Viruses.2021; 13(2): 297.     CrossRef
• Clinical Pharmacology of Bacteriophage Therapy: A Focus on Multidrug-Resistant Pseudomonas aeruginosa Infections
  Dana Holger, Razieh Kebriaei, Taylor Morrisette, Katherine Lev, Jose Alexander, Michael Rybak
  Antibiotics.2021; 10(5): 556.     CrossRef
• Characteristics of a Bacteriophage, vB_Kox_ZX8, Isolated From Clinical Klebsiella oxytoca and Its Therapeutic Effect on Mice Bacteremia
  Ping Li, Yangheng Zhang, Fuhua Yan, Xin Zhou
  Frontiers in Microbiology.2021;[Epub]     CrossRef
• Reapproaching Old Treatments: Considerations for PK/PD Studies on Phage Therapy for Bacterial Respiratory Infections
  Alan A. Schmalstig, Soha Freidy, Patrick O. Hanafin, Miriam Braunstein, Gauri G. Rao
  Clinical Pharmacology & Therapeutics.2021; 109(6): 1443.     CrossRef
• A single dose of a virulent bacteriophage vB PaeP-SaPL, rescues bacteremic mice infected with multi drug resistant Pseudomonas aeruginosa
  Iqbal Ahmad Alvi, Muhammad Asif, Shafiq ur Rehman
  Virus Research.2021; 292: 198250.     CrossRef
• Antiviral effect of a bacteriophage on murine norovirus replication via modulation of the innate immune response
  Lili Zhang, Chang Ma, Jie Liu, Khashayar Shahin, Xiang Hou, Lichang Sun, Heye Wang, Ran Wang
  Virus Research.2021; 305: 198572.     CrossRef
• Bacteriophages as an Alternative Method for Control of Zoonotic and Foodborne Pathogens
  Mohammed Mijbas Mohammed Alomari, Marta Dec, Renata Urban-Chmiel
  Viruses.2021; 13(12): 2348.     CrossRef
• Formulation strategies for bacteriophages to target intracellular bacterial pathogens
  Wei Yan, Parikshit Banerjee, Miao Xu, Subhankar Mukhopadhyay, Margaret Ip, Nicholas B. Carrigy, David Lechuga-Ballesteros, Kenneth Kin Wah To, Sharon S.Y. Leung
  Advanced Drug Delivery Reviews.2021; 176: 113864.     CrossRef
• Characterization of a Novel Bacteriophage Henu2 and Evaluation of the Synergistic Antibacterial Activity of Phage-Antibiotics
  Xianghui Li, Tongxin Hu, Jiacun Wei, Yuhua He, Abualgasim Elgaili Abdalla, Guoying Wang, Yanzhang Li, Tieshan Teng
  Antibiotics.2021; 10(2): 174.     CrossRef
• Therapeutic Perspectives and Mechanistic Insights of Phage Therapy in Allotransplantation
  Kenneth J. Dery, Andrzej Górski, Ryszard Międzybrodzki, Douglas G. Farmer, Jerzy W. Kupiec-Weglinski
  Transplantation.2021; 105(7): 1449.     CrossRef
• How to kill Pseudomonas—emerging therapies for a challenging pathogen
  Luke N. Yaeger, Victoria E. Coles, Derek C. K. Chan, Lori L. Burrows
  Annals of the New York Academy of Sciences.2021; 1496(1): 59.     CrossRef
• Bacteriophages and the Immune System
  Medeea Popescu, Jonas D. Van Belleghem, Arya Khosravi, Paul L. Bollyky
  Annual Review of Virology.2021; 8(1): 415.     CrossRef
• Synergistic Killing and Re-Sensitization of Pseudomonas aeruginosa to Antibiotics by Phage-Antibiotic Combination Treatment
  Emily Engeman, Helen R. Freyberger, Brendan W. Corey, Amanda M. Ward, Yunxiu He, Mikeljon P. Nikolich, Andrey A. Filippov, Stuart D. Tyner, Anna C. Jacobs
  Pharmaceuticals.2021; 14(3): 184.     CrossRef
• Pharmacokinetics and Pharmacodynamics of a Novel Virulent Klebsiella Phage Kp_Pokalde_002 in a Mouse Model
  Gunaraj Dhungana, Roshan Nepal, Madhav Regmi, Rajani Malla
  Frontiers in Cellular and Infection Microbiology.2021;[Epub]     CrossRef
• Interactions of Bacteriophages with Animal and Human Organisms—Safety Issues in the Light of Phage Therapy
  Magdalena Podlacha, Łukasz Grabowski, Katarzyna Kosznik-Kawśnicka, Karolina Zdrojewska, Małgorzata Stasiłojć, Grzegorz Węgrzyn, Alicja Węgrzyn
  International Journal of Molecular Sciences.2021; 22(16): 8937.     CrossRef
• A Review of Using Mathematical Modeling to Improve Our Understanding of Bacteriophage, Bacteria, and Eukaryotic Interactions
  Kathryn M. Styles, Aidan T. Brown, Antonia P. Sagona
  Frontiers in Microbiology.2021;[Epub]     CrossRef
• Impact of Frequent Administration of Bacteriophage on Therapeutic Efficacy in an A. baumannii Mouse Wound Infection Model
  Michael D. Rouse, Joshua Stanbro, Jessica A. Roman, Michelle A. Lipinski, Anna Jacobs, Biswaijt Biswas, James Regeimbal, Matthew Henry, Michael G. Stockelman, Mark P. Simons
  Frontiers in Microbiology.2020;[Epub]     CrossRef
• Phage therapy efficacy: a review of the last 10 years of preclinical studies
  Luís D. R. Melo, Hugo Oliveira, Diana P. Pires, Krystyna Dabrowska, Joana Azeredo
  Critical Reviews in Microbiology.2020; 46(1): 78.     CrossRef
• RLP, a bacteriophage of the family Podoviridae, rescues mice from bacteremia caused by multi-drug-resistant Pseudomonas aeruginosa
  Iqbal Ahmad Alvi, Muhammad Asif, Rabia Tabassum, Rehan Aslam, Zaigham Abbas, Shafiq ur Rehman
  Archives of Virology.2020; 165(6): 1289.     CrossRef
• Pf Bacteriophage and Their Impact on Pseudomonas Virulence, Mammalian Immunity, and Chronic Infections
  Patrick R. Secor, Elizabeth B. Burgener, M. Kinnersley, Laura K. Jennings, Valery Roman-Cruz, Medeea Popescu, Jonas D. Van Belleghem, Naomi Haddock, Conner Copeland, Lia A. Michaels, Christiaan R. de Vries, Qingquan Chen, Julie Pourtois, Travis J. Wheeler
  Frontiers in Immunology.2020;[Epub]     CrossRef
• Fitness Trade-Offs Resulting from Bacteriophage Resistance Potentiate Synergistic Antibacterial Strategies
  Mihnea R. Mangalea, Breck A. Duerkop, Karen M. Ottemann
  Infection and Immunity.2020;[Epub]     CrossRef
• Phage therapy: What factors shape phage pharmacokinetics and bioavailability? Systematic and critical review
  Krystyna Dąbrowska
  Medicinal Research Reviews.2019; 39(5): 2000.     CrossRef
• Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies
  Krystyna Dąbrowska, Stephen T. Abedon
  Microbiology and Molecular Biology Reviews.2019;[Epub]     CrossRef
• Biological challenges of phage therapy and proposed solutions: a literature review
  Katherine M Caflisch, Gina A Suh, Robin Patel
  Expert Review of Anti-infective Therapy.2019; 17(12): 1011.     CrossRef
• Interactions between Bacteriophage, Bacteria, and the Mammalian Immune System
  Jonas D. Van Belleghem, Krystyna Dąbrowska, Mario Vaneechoutte, Jeremy J. Barr, Paul L. Bollyky
  Viruses.2018; 11(1): 10.     CrossRef
• Proof-of-Principle Study in a Murine Lung Infection Model of Antipseudomonal Activity of Phage PEV20 in a Dry-Powder Formulation
  Rachel Yoon Kyung Chang, Ke Chen, Jiping Wang, Martin Wallin, Warwick Britton, Sandra Morales, Elizabeth Kutter, Jian Li, Hak-Kim Chan
  Antimicrobial Agents and Chemotherapy.2018;[Epub]     CrossRef
• Challenges and Promises for Planning Future Clinical Research Into Bacteriophage Therapy Against Pseudomonas aeruginosa in Cystic Fibrosis. An Argumentative Review
  Martina Rossitto, Ersilia V. Fiscarelli, Paola Rosati
  Frontiers in Microbiology.2018;[Epub]     CrossRef
• Phage-Phagocyte Interactions and Their Implications for Phage Application as Therapeutics
  Ewa Jończyk-Matysiak, Beata Weber-Dąbrowska, Barbara Owczarek, Ryszard Międzybrodzki, Marzanna Łusiak-Szelachowska, Norbert Łodej, Andrzej Górski
  Viruses.2017; 9(6): 150.     CrossRef
• Modeling the synergistic elimination of bacteria by phage and the innate immune system
  Chung Yin (Joey) Leung, Joshua S. Weitz
  Journal of Theoretical Biology.2017; 429: 241.     CrossRef
• Characterization and complete genome sequence analysis of two Myoviral bacteriophages infecting clinical carbapenem‐resistant Acinetobacter baumannii isolates
  J. Jeon, R. D'Souza, N. Pinto, C.‐M. Ryu, J. Park, D. Yong, K. Lee
  Journal of Applied Microbiology.2016; 121(1): 68.     CrossRef
• Phage Therapy: a Step Forward in the Treatment of Pseudomonas aeruginosa Infections
  Diana P. Pires, Diana Vilas Boas, Sanna Sillankorva, Joana Azeredo, S. P. Goff
  Journal of Virology.2015; 89(15): 7449.     CrossRef
• The Effect of Bacteriophage Preparations on Intracellular Killing of Bacteria by Phagocytes
  Ewa Jończyk-Matysiak, Marzanna Łusiak-Szelachowska, Marlena Kłak, Barbara Bubak, Ryszard Międzybrodzki, Beata Weber-Dąbrowska, Maciej Żaczek, Wojciech Fortuna, Paweł Rogóż, Sławomir Letkiewicz, Krzysztof Szufnarowski, Andrzej Górski
  Journal of Immunology Research.2015; 2015: 1.     CrossRef
• Bacteriophages and Biofilms
  David Harper, Helena Parracho, James Walker, Richard Sharp, Gavin Hughes, Maria Werthén, Susan Lehman, Sandra Morales
  Antibiotics.2014; 3(3): 270.     CrossRef
• Phage fitness may help predict phage therapy efficacy
  Heather M Lindberg, Kurt A McKean, Ing-Nang Wang
  Bacteriophage.2014; 4(4): e964081.     CrossRef
• Bacteriophages and Their Derivatives as Biotherapeutic Agents in Disease Prevention and Treatment
  Mohamed Elbreki, R. Paul Ross, Colin Hill, Jim O'Mahony, Olivia McAuliffe, Aidan Coffey
  Journal of Viruses.2014; 2014: 1.     CrossRef
• Phage Therapy Is Effective against Infection by Mycobacterium ulcerans in a Murine Footpad Model
  Gabriela Trigo, Teresa G. Martins, Alexandra G. Fraga, Adhemar Longatto-Filho, António G. Castro, Joana Azeredo, Jorge Pedrosa, Christian Johnson
  PLoS Neglected Tropical Diseases.2013; 7(4): e2183.     CrossRef
• Use of bacteriophages in the treatment ofPseudomonas aeruginosainfections
  James Soothill
  Expert Review of Anti-infective Therapy.2013; 11(9): 909.     CrossRef